Abstract
The international American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) tumour-node-metastasis (TNM) staging system provides the current guidelines for the classification of cancer. However, among patients within the same stage, the clinical outcome can be very different. More recently, a novel definition of cancer has emerged, implicating at all stages a complex and dynamic interaction between tumour cells and the immune system. This has enabled the definition of the immune contexture, representing the pre-existing immune parameters associated with patient survival. Even so, the role of distinct immune cell types in modulating cancer progression is increasingly emerging. An immune-based assay named the 'Immunoscore' was defined to quantify the in situ T cell infiltrate and was demonstrated to be superior to the AJCC/UICC TNM classification for patients with colorectal cancer. This Review provides a broad overview of the main immune parameters positively or negatively shaping cancer development, including the Immunoscore, and their prognostic and predictive value. The importance of the immune system in cancer control is demonstrated by the requirement for a pre-existing intratumour adaptive immune response for effective immunotherapies, such as checkpoint inhibitors. Finally, we discuss how the combination of multiple immune parameters, rather than individual ones, might increase prognostic and/or predictive power.
Keywords
Immune systemMedicineCancerOncologyIntensive care medicineInternal medicineImmunology
MeSH Terms
Antineoplastic AgentsImmunologicalBiomarkersTumorColorectal NeoplasmsDisease ProgressionHumansImmune Checkpoint InhibitorsImmune SystemImmunoassayNeoplasm StagingNeoplasmsPredictive Value of TestsPrognosisRisk AssessmentSeverity of Illness IndexSurvival AnalysisTreatment Outcome
Affiliated Institutions
- Centre Roland Mousnier
- Université Paris Cité FR
- Inserm FR
- Sciences, Normes, Démocratie
- Sorbonne Université FR
- Centre de Recherche en Littérature Comparée
- Laboratoire d’immunologie intégrative du cancer FR
- Victor (Japan) JP
- Centre de linguistique en Sorbonne
- AstraZeneca (United Kingdom) GB
- Centre de Recherche des Cordeliers FR
- La Ligue Contre le Cancer FR
- Laboratoire Médiations
- Sorbonne Paris Cité FR
Related Publications
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Purpose The prognosis of patients with colorectal cancer has sometimes proved uncertain; thus, the prognostic significance of immune criteria was compared with that of the tumor...
Frequency of regulatory T cells in peripheral blood and in tumour‐infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma
What’s known on the subject? and What does the study add? Treg overexpression has been demonstrated in several neoplasms, including liver, breast, pancreas and melanoma, while i...
Prognostic value of intratumoral CD8<sup>+</sup> T lymphocyte in extrahepatic bile duct carcinoma as essential immune response
Abstract Background and Objectives Tumor‐infiltrating lymphocytes form an important aspect of the host defense against an expanding neoplasm. CD8 + T cells have been identified ...
The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase‐2 expression in clear cell renal cell carcinoma
OBJECTIVE To investigate the prognostic value of regulatory T cells (Tregs) and its correlation with cyclooxygenase‐2 (COX‐2) expression in clear cell renal cell carcinoma (RCC)...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 20
- Issue
- 11
- Pages
- 662-680
- Citations
- 1533
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1533
OpenAlex
0
Influential
Cite This
Daniela Bruni,
Helen K. Angell,
Jérôme Galon
(2020).
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
Nature reviews. Cancer
, 20
(11)
, 662-680.
https://doi.org/10.1038/s41568-020-0285-7
Identifiers
- DOI
- 10.1038/s41568-020-0285-7
- PMID
- 32753728